The Relationship Between Vascular Adhesion Protein-1 and Diabetic Cardiovascular Autonomic Neuropathy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01706289
First received: October 10, 2012
Last updated: October 12, 2012
Last verified: September 2012
  Purpose

Exploring the relationship between serum VAP-1 and cardiovascular autonomic neuropathy in subjects with type 2 diabetes mellitus


Condition
Neuropathy; Peripheral, Autonomic, in Diabetes Mellitus (Manifestation)

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: The Relationship Between Vascular Adhesion Protein-1 and Diabetic Cardiovascular Autonomic Neuropathy

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Biospecimen Retention:   Samples With DNA

whole blood


Estimated Enrollment: 150
Study Start Date: March 2009
Estimated Study Completion Date: May 2014
Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
diabetic mellitus screen

Detailed Description:

The prevalence of diabetes mellitus is increasing recently, especially in the urban area of developing countries. Subjects with diabetes have higher rate of hospitalization and have higher mortality. Diabetes results in various complications including diabetic retinopathy, nephropathy, neuropathy, and cardiovascular complications. Among these, cardiovascular autonomic neuropathy is one of clinical important complication of diabetes. Diabetic subjects with reduced cardiovascular autonomic function have been shown to strongly associate with an increased risk of silent myocardial ischemia and increased mortality. They also have higher risk of sudden death, intraoperative and perioperative cardiovascular instability. Formation of advanced glycation end product (AGE) and oxidative stress are important causes of diabetic neuropathy. Vascular adhesion protein-1 (VAP-1), an adhesion molecule with an activity of semicarbazide-sensitive amine oxidases (SSAO), which can catalyze endogenous amines to produces corresponding aldehydes, H2O2, and ammonia. We have demonstrated that serum VAP-1 is a source of systemic AGE and oxidative stress, and is associated with nephropathy and atherosclerosis. There are reports demonstrating that subjects with diabetic retinopathy or stroke have higher serum VAP-1. To our best knowledge, there is no report regarding the relationship between serum VAP-1 and neuropathy. In present study, we will measure serum VAP-1 and check cardiovascular autonomic function. We will also explore the relationship between serum VAP-1 and cardiovascular autonomic neuropathy in subjects with type 2 diabetes mellitus.

  Eligibility

Ages Eligible for Study:   10 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

type 2 diabetes mellitus

Criteria

Inclusion Criteria:

  • type 2 diabetes mellitus

Exclusion Criteria:

  • arrythmia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01706289

Contacts
Contact: Ying-Chuen Lai 886-02-23123456 ext 63678 ying.chuen@msa.hinet.net

Locations
Taiwan
National Taiwan University Hospital Recruiting
Yun Lin, Taiwan
Contact: Ying-Chuen Lai    886-05-5323911 ext 5125    ying.chuen@msa.hinet.net   
Principal Investigator: Ying-Chuen Lai         
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Study Chair: Hung-Yaun Li National Taiwan University Hospital
  More Information

No publications provided

Responsible Party: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT01706289     History of Changes
Other Study ID Numbers: NTUH20090323HRV
Study First Received: October 10, 2012
Last Updated: October 12, 2012
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
diabetes
cardiovascular autonomic neuropathy
VAP 1

Additional relevant MeSH terms:
Diabetes Mellitus
Nervous System Diseases
Peripheral Nervous System Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Neuromuscular Diseases

ClinicalTrials.gov processed this record on October 21, 2014